SenzaGen AB

SSE:SENZA.ST

6.7 (SEK) • At close February 19, 2024
Bedrijfsnaam SenzaGen AB
Symbool SENZA.ST
Munteenheid SEK
Prijs 6.7
Beurswaarde 161,234,830
Dividendpercentage 0%
52-weken bereik 6.08 - 13.1
Industrie Diagnostics & Research
Sector Healthcare
CEO Mr. Peter Nahlstedt
Website https://senzagen.com

An error occurred while fetching data.

Over SenzaGen AB

SenzaGen AB develops, performs, and sells non-animal tests for assessing a substance's allergenicity. The company offers genomic allergen rapid detection (GARD)skin, an in vitro test to identify potential chemical skin sensitizers; GARDpotency, an in vitro add-on test to GARDskin for potency classification; GARDskin Dose-response, an in vitro test for quantitative

Vergelijkbare Aandelen

AcouSort AB (publ) logo

AcouSort AB (publ)

ACOU.ST

13.2 SEK

Magle Chemoswed Holding AB (publ) logo

Magle Chemoswed Holding AB (publ)

MAGLE.ST

27.6 SEK

Clinical Laserthermia Systems AB (publ) logo

Clinical Laserthermia Systems AB (publ)

CLS-B.ST

0.102 SEK

ProstaLund AB (publ) logo

ProstaLund AB (publ)

PLUN.ST

1.575 SEK

Active Biotech AB (publ) logo

Active Biotech AB (publ)

ACTI.ST

0.685 SEK

Abliva AB (publ) logo

Abliva AB (publ)

ABLI.ST

0.238 SEK

Financiële Gegevens

Cijfers zijn in miljoenen (SEK)

Cijfers zijn in miljoenen (SEK)